Market revenue in 2023 | USD 15.9 million |
Market revenue in 2030 | USD 56.9 million |
Growth rate | 20% (CAGR from 2023 to 2030) |
Largest segment | Cell & gene therapy |
Fastest growing segment | Cell & Gene Therapy |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cell & Gene Therapy, Immunotherapy |
Key market players worldwide | Charles River Laboratories International Inc, Boehringer Ingelheim, Thermo Fisher Scientific Inc, Lonza Group Ltd, Viva Biotech, VGXI, PlasmidFactory, BioCina, TriLink BioTechnologies, Esco Aster |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna contract manufacturing market will help companies and investors design strategic landscapes.
Cell & gene therapy was the largest segment with a revenue share of 60.38% in 2023. Horizon Databook has segmented the UK plasmid dna contract manufacturing market based on cell & gene therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing geriatric population and growing prevalence of chronic diseases, such as chronic liver disease, diabetes, infectious diseases, genetic diseases, cardiovascular diseases, & cancer, are the primary factors contributing to market growth.
Presence of a large number of players and the strategic initiatives undertaken by them, such as acquisitions & expansion of therapeutic options, would increase contract manufacturing of pDNA and would also fulfill the requirements of pharmaceutical & biotech companies in terms of quality standards and manufacturing with help of the contract manufacturing firms.
Horizon Databook provides a detailed overview of country-level data and insights on the UK plasmid dna contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into UK plasmid dna contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account